Literature DB >> 25337527

Evaluation of the analgesic effect of subcutaneous methadone after cesarean section.

Mitra Jabalameli1, Forough Kalantari2.   

Abstract

BACKGROUND: Inadequate pain control has a significant role in maternal and neonatal health in early post-partum period which interferes with breastfeeding and has a negative influence on child normal growth. The aim of this study is evaluation of subcutaneous methadone effectiveness on post-operative pain control.
MATERIALS AND METHODS: Double blind randomized prospective clinical trial involving 60 term pregnancy patients through 2008 to 2009 Undergo cesarean. INCLUSION CRITERIA: Prime gravid candidate of elective cesarean and spinal anesthesia class 1 or 2. Known case of drug allergy and methadone interaction, addiction, uncontrolled medical disease excluded. Case group injected 10 mg of subcutaneous methadone in the site of incision before final suture. Morphine was a pain reliever in follow up examination. Data include mean of pain, nausea and vomiting, MAP, etc., collected and analyzed by independent-T test and Man Whitney test.
RESULTS: Although mean usage of morphine between groups was not significant statistically but the mean pain severity (P value < 0.05) and mean satisfactory (P value = 0.02) was statistically significant between groups. Other parameters were not statistically significant.
CONCLUSION: We suggest subcutaneous methadone as a safe pain reliever in post cesarean section patients.

Entities:  

Keywords:  Cesarean; morphine; pain control; subcutaneous methadone

Year:  2014        PMID: 25337527      PMCID: PMC4202502          DOI: 10.4103/2277-9175.140679

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


  11 in total

1.  Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.

Authors:  S Mercadante; M Sapio; R Serretta; M Caligara
Journal:  Ann Oncol       Date:  1996-08       Impact factor: 32.976

2.  Methadone is safe for treating hospitalized patients with severe pain.

Authors:  Y Shir; G Rosen; A Zeldin; E M Davidson
Journal:  Can J Anaesth       Date:  2001-12       Impact factor: 5.063

3.  Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing.

Authors:  E J Begg; T J Malpas; L P Hackett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

4.  Subcutaneous methadone in terminally ill patients: manageable local toxicity.

Authors:  P Mathew; P Storey
Journal:  J Pain Symptom Manage       Date:  1999-07       Impact factor: 3.612

5.  Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study.

Authors:  I L Mancini; J Hanson; C M Neumann; E D Bruera
Journal:  J Palliat Med       Date:  2000       Impact factor: 2.947

6.  Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain.

Authors:  B Gagnon; E Bruera
Journal:  J Pain Symptom Manage       Date:  1999-08       Impact factor: 3.612

Review 7.  Methadone use in cancer patients with pain: a review.

Authors:  Eduardo Bruera; Catherine Sweeney
Journal:  J Palliat Med       Date:  2002-02       Impact factor: 2.947

8.  Intermittent subcutaneous methadone administration in the management of cancer pain.

Authors:  Carlos Centeno; Francisco Vara
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

9.  Methadone reincarnated: novel clinical applications with related concerns.

Authors:  Scott M Fishman; Barth Wilsey; Gagan Mahajan; Patricia Molina
Journal:  Pain Med       Date:  2002-12       Impact factor: 3.750

Review 10.  Postoperative pain management in obstetric anesthesia--new challenges and solutions.

Authors:  Albert Y Leung
Journal:  J Clin Anesth       Date:  2004-02       Impact factor: 9.452

View more
  1 in total

Review 1.  New Pain Management Options for the Surgical Patient on Methadone and Buprenorphine.

Authors:  Sudipta Sen; Sailesh Arulkumar; Elyse M Cornett; Julie A Gayle; Ronda R Flower; Charles J Fox; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.